1,323
Views
40
CrossRef citations to date
0
Altmetric
Review

Diet and prevention of type 2 diabetes mellitus: beyond weight loss and exercise

, & ORCID Icon
Pages 1-12 | Received 28 Sep 2018, Accepted 28 Nov 2018, Published online: 06 Dec 2018

References

  • Centers for Disease Control and Prevention. National diabetes statistics report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017. [cited 2018 Sep 24]. Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html
  • IDF Diabetes Atlas Website. 8th Edition. Key messages; [ cited 2018 Sep 24] Available from: http://www.diabetesatlas.org/key-messages.html
  • Defronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–795. Banting Lecture.
  • Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130–1139.
  • Alatrach M, Agyin C, Mehta R, et al. Glucose-mediated glucose disposal at baseline insulin is impaired in IFG. J Clin Endocrinol Metab. 2018.
  • DeFronzo RA, Abdul-Ghani MA. Preservation of beta-cell function: the key to diabetes prevention. J Clin Endocrinol Metab. 2011;96(8):2354–2366.
  • Rojas JM, Schwartz MW. Control of hepatic glucose metabolism by islet and brain. Diabetes Obes Metab. 2014;16(Suppl 1):33–40.
  • Gastaldelli A. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;93(Suppl 1):S60–65.
  • Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes. 2002;51(Suppl 1):S109–116.
  • Hayashi T, Boyko EJ, Sato KK, et al. Patterns of insulin concentration during the OGTT predict the risk of type 2 diabetes in Japanese Americans. Diabetes Care. 2013;36(5):1229–1235.
  • Gastaldelli A, Ferrannini E, Miyazaki Y, et al. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia. 2004;47(1):31–39.
  • Crofts C, Schofield G, Zinn C, et al. Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: an examination of the kraft database. Diabetes Res Clin Pract. 2016;118:50–57.
  • Robertson RP. Beta-cell deterioration during diabetes: what’s in the gun? Trends Endocrinol Metab. 2009;20(8):388–393.
  • Stumvoll M, Fritsche A, Hu H. Clinical characterization of insulin secretion as the basis for genetic analyses. Diabetes. 2002;51(Suppl 1):S122–129.
  • Aune D, Norat T, Leitzmann M, et al. Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Epidemiol. 2015;30(7):529–542.
  • Jelleyman C, Yates T, O’Donovan G, et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev. 2015;16(11):942–961.
  • Schreuder TH, Maessen MF, Tack CJ, et al. Life-long physical activity restores metabolic and cardiovascular function in type 2 diabetes. Eur J Appl Physiol. 2014;114(3):619–627.
  • Grams J, Garvey WT. Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep. 2015;4(2):287–302.
  • Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
  • Glechner A, Keuchel L, Affengruber L, et al. Effects of lifestyle changes on adults with prediabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2018;12(5):393–408.
  • Ramachandran A, Snehalatha C, Mary S, et al. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–297.
  • Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care. 2014;37(4):943–949.
  • Haw JS, Galaviz KI, Straus AN, et al. Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017;177(12):1808–1817.
  • National Institute of Diabetes and Digestive and Kidney Diseases. Questions & answers about the diabetes prevention programs and outcomes study; 2009 Oct [cited 2018 Sep 20]. Avaiable from: https://www.niddk.nih.gov/news/for-reporters/diabetes-prevention-program-outcomes-study/questions-answers
  • Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22.
  • le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389(10077):1399–1409.
  • American Diabetes Association. 5. Prevention or delay of type 2 diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41(Suppl. 1):S51–S54.
  • Garber AJ, Abrahamson MJ, Barzilay JI, et al. consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm—2018 executive summary. Endocr Pract. 2018;24(1):91–120.
  • Bethel MA, Xu W, Theodorakis MJ. Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus. Diabetes Obes Metab. 2015;17(3):231–244.
  • Stevens JW, Khunti K, Harvey R, et al. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Res Clin Pract. 2015;107(3):320–331.
  • Samson SL, Garber AJ. Prevention of type 2 diabetes mellitus: potential of pharmacological agents. Best Pract Res Clin Endocrinol Metab. 2016;30(3):357–371.
  • Davis C, Bryan J, Hodgson J, et al. Definition of the Mediterranean diet; a literature review. Nutrients. 2015;7(11):9139–9153.
  • U.S. Department of health and human services and U.S. department of agriculture. 2015–2020 Dietary guidelines for Americans. 8th Edition; Dec 2015 [cited 2018 Sep 20]. Available from: http://health.gov/dietaryguidelines/2015/guidelines/Last
  • Estruch R, Ros E, Salas-Salvado J, et al. Retraction and republication: primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–1290. N Engl J Med, 378(25),2441–2442 (2018).
  • Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145(1):1–11.
  • Salas-Salvado J, Bullo M, Babio N, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the predimed-reus nutrition intervention randomized trial. Diabetes Care. 2011;34(1):14–19.
  • Salas-Salvadó J, Bulló M, Babio N, et al. Erratum. reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the predimed-reus nutrition intervention randomized trial. Diabetes Care. 2011;34:14–19. Diabetes Care, 41 (10),2259–2260(2018).
  • Jannasch F, Kroger J, Schulze MB. Dietary patterns and type 2 diabetes: a systematic literature review and meta-analysis of prospective studies. J Nutr. 2017;147(6):1174–1182.
  • Blumenthal JA, Babyak MA, Sherwood A, et al. Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension. 2010;55(5):1199–1205.
  • Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med. 1997;336(16):1117–1124.
  • Krishnan S, Adams SH, Allen LH, et al. A randomized controlled-feeding trial based on the dietary guidelines for Americans on cardiometabolic health indexes. Am J Clin Nutr. 2018;108(2):266–278.
  • U.S. Department of health and human services and U.S. department of agriculture. 2015—2020 Dietary guidelines for Americans. 8th Edition; Dec 2015. Available from https://health.gov/dietaryguidelines/2015/guidelines/.).
  • 2015 Advisory Report, Office of Disease Prevention and Health Promotion. [ cited 20 Sep 2018]. Available from: https://health.gov/dietaryguidelines/2015-scientific-report/Last
  • Li M, Fan Y, Zhang X, et al. Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies. BMJ Open. 2014;4(11):e005497.
  • Muraki I, Imamura F, Manson JE, et al. Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. BMJ. 2013;347:f5001.
  • Khoo HE, Azlan A, Tang ST, et al. Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr Res. 2017;61(1):1361779.
  • Weickert MO, Pfeiffer AFH. Impact of dietary fiber consumption on insulin resistance and the prevention of type 2 diabetes. J Nutr. 2018;148(1):7–12.
  • Wang PY, Fang JC, Gao ZH, et al. Higher intake of fruits, vegetables or their fiber reduces the risk of type 2 diabetes: A meta-analysis. J Diabetes Investig. 2016;7(1):56–69.
  • Fang X, Han H, Li M, et al. Dose-response relationship between dietary magnesium intake and risk of type 2 diabetes mellitus: a systematic review and meta-regression analysis of prospective cohort studies. Nutrients. 2016;8(11).
  • Hruby A, Guasch-Ferre M, Bhupathiraju SN, et al. Magnesium intake, quality of carbohydrates, and risk of type 2 diabetes: results from three U.S. Cohorts. Diabetes Care. 2017;40(12):1695–1702.
  • Wu J, Xun P, Tang Q, et al. Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Nutr J. 2017;16(1):60.
  • Fang X, Wang K, Han D, et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med. 2016;14(1):210.
  • Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, et al. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res. 2016;111:272–282.
  • Veronese N, Watutantrige-Fernando S, Luchini C, et al. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr. 2016;70(12):1354–1359.
  • US Department of agriculture (USDA), agricultural research service, nutrient data laboratory. USDA national nutrient database for standard reference, legacy; Version Current: Apr 2018 [cited 2018 Sep 24]. Available from: http://www.ars.usda.gov/nutrientdata
  • Afshin A, Micha R, Khatibzadeh S, et al. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100(1):278–288.
  • Aune D, Norat T, Romundstad P, et al. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr. 2013;98(4):1066–1083.
  • Kyro C, Tjonneland A, Overvad K, et al. Higher whole-grain intake is associated with lower risk of type 2 diabetes among middle-aged men and women: the Danish diet, cancer, and health cohort. J Nutr. 2018;148(9):1434–1444.
  • Office of Nutrition and Food Labeling. The declaration of certain isolated or synthetic non-digestible carbohydrates as dietary fiber on nutrition and supplement facts labels: guidance for industry. College Park, MD: Food and Drug Administration (US); 2018. (FDA-2018-D-1323).
  • Office of Nutrition and Food Labeling. Review of the scientific evidence on the physiological effects of certain non-digestible carbohydrates. College Park, MD: Food and Drug Administration (US); 2018.
  • Maki KC, Phillips AK. Dietary substitutions for refined carbohydrate that show promise for reducing risk of type 2 diabetes in men and women. J Nutr. 2015;145(1):159S–163S.
  • Carlson JL, Erickson JM, Hess JM, et al. Prebiotic dietary fiber and gut health: comparing the in vitro fermentations of beta-glucan, inulin and xylooligosaccharide. Nutrients. 2017;9(12).
  • Cho SS, Qi L, Fahey GC, et al. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr. 2013;98(2):594–619.
  • Babio N, Balanza R, Basulto J, et al. Dietary fibre: influence on body weight, glycemic control and plasma cholesterol profile. Nutr Hosp. 2010;25(3):327–340.
  • Honsek C, Kabisch S, Kemper M, et al. Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled optimal fibre trial (OptiFiT). Diabetologia. 2018;61(6):1295–1305.
  • Goletzke J, Herder C, Joslowski G, et al. Habitually higher dietary glycemic index during puberty is prospectively related to increased risk markers of type 2 diabetes in younger adulthood. Diabetes Care. 2013;36(7):1870–1876.
  • Bhupathiraju SN, Tobias DK, Malik VS, et al. Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr. 2014;100(1):218–232.
  • Ojo O, Ojo OO, Adebowale F, et al. The effect of dietary glycaemic index on glycaemia in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2018;10(3).
  • Holt SH, Miller JC, Petocz P. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr. 1997;66(5):1264–1276.
  • Mirmiran P, Esfandiari S, Bahadoran Z, et al. Dietary insulin load and insulin index are associated with the risk of insulin resistance: a prospective approach in tehran lipid and glucose study. J Diabetes Metab Disord. 2015;15:23.
  • Nimptsch K, Brand-Miller JC, Franz M, et al. Dietary insulin index and insulin load in relation to biomarkers of glycemic control, plasma lipids, and inflammation markers. Am J Clin Nutr. 2011;94(1):182–190.
  • Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. a consensus report by the american diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care. 2018;41(12):2669–2701.
  • Nanri A, Mizoue T, Kurotani K, et al. Low-carbohydrate diet and type 2 diabetes risk in Japanese men and women: the Japan public health center-based prospective study. PLoS One. 2015;10(2):e0118377.
  • de Koning L, Fung TT, Liao X, et al. Low-carbohydrate diet scores and risk of type 2 diabetes in men. Am J Clin Nutr. 2011;93(4):844–850.
  • Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359(9323):2072–2077.
  • Kawamori R, Tajima N, Iwamoto Y, et al. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet. 2009;373(9675):1607–1614.
  • Maki KC, Eren F, Cassens ME, et al. Omega-6 polyunsaturated fatty acids and cardiometabolic health: current evidence, controversies, and research gaps. Adv Nutr. 2018.
  • Wu JHY, Marklund M, Imamura F, et al. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol. 2017;5(12):965–974.
  • Forouhi NG, Imamura F, Sharp SJ, et al. Association of plasma phospholipid n-3 and n-6 polyunsaturated fatty acids with type 2 diabetes: the EPIC-interact case-cohort study. PLoS Med. 2016;13(7):e1002094.
  • Schwingshackl L, Lampousi AM, Portillo MP, et al. Olive oil in the prevention and management of type 2 diabetes mellitus: a systematic review and meta-analysis of cohort studies and intervention trials. Nutr Diabetes. 2017;7(4):e262.
  • Imamura F, Micha R, Wu JH, et al. Effects of saturated fat, polyunsaturated fat, monounsaturated fat, and carbohydrate on glucose-insulin homeostasis: a systematic review and meta-analysis of randomised controlled feeding trials. PLoS Med. 2016;13(7):e1002087.
  • Schwingshackl L, Hoffmann G, Lampousi AM, et al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2017;32(5):363–375.
  • Malik VS. Sugar sweetened beverages and cardiometabolic health. Curr Opin Cardiol. 2017;32(5):572–579.
  • Imamura F, O’Connor L, Ye Z, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. Br J Sports Med. 2016;50(8):496–504.
  • Romo-Romo A, Aguilar-Salinas CA, Brito-Cordova GX, et al. Effects of the non-nutritive sweeteners on glucose metabolism and appetite regulating hormones: systematic review of observational prospective studies and clinical trials. PLoS One. 2016;11(8):e0161264.
  • Alkhatib A, Tsang C, Tiss A, et al. Functional foods and lifestyle approaches for diabetes prevention and management. Nutrients. 2017;9(12).
  • Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133(2):187–225.
  • van Dam RM, Willett WC, Manson JE, et al. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care. 2006;29(2):398–403.
  • Kerr WC, Ye Y. Relationship of life-course drinking patterns to diabetes, heart problems, and hypertension among those 40 and older in the 2005 U.S. national alcohol survey. J Stud Alcohol Drugs. 2010;71(4):515–525.
  • Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care. 2015;38(9):1804–1812.
  • Schrieks IC, Heil AL, Hendriks HF, et al. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes Care. 2015;38(4):723–732.
  • Hirahatake KM, Slavin JL, Maki KC, et al. Associations between dairy foods, diabetes, and metabolic health: potential mechanisms and future directions. Metabolism. 2014;63(5):618–627.
  • Sluijs I, Forouhi NG, Beulens JW, et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr. 2012;96(2):382–390.
  • Maki KC, Nieman KM, Schild AL, et al. Sugar-sweetened product consumption alters glucose homeostasis compared with dairy product consumption in men and women at risk of type 2 diabetes mellitus. J Nutr. 2015;145(3):459–466.
  • Turner KM, Keogh JB, Clifton PM. Red meat, dairy, and insulin sensitivity: a randomized crossover intervention study. Am J Clin Nutr. 2015;101(6):1173–1179.
  • Chen M, Sun Q, Giovannucci E, et al. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med. 2014;12:215.
  • Ericson U, Hellstrand S, Brunkwall L, et al. Food sources of fat may clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr. 2015;101(5):1065–1080.
  • Panahi S, Tremblay A. The potential role of yogurt in weight management and prevention of type 2 diabetes. J Am Coll Nutr. 2016;35(8):717–731.
  • He C, Shan Y, Song W. Targeting gut microbiota as a possible therapy for diabetes. Nutr Res. 2015;35(5):361–367.
  • Rains TM, Leidy HJ, Sanoshy KD, et al. A randomized, controlled, crossover trial to assess the acute appetitive and metabolic effects of sausage and egg-based convenience breakfast meals in overweight premenopausal women. Nutr J. 2015;14:17.
  • Palacios OM, Edirisinghe I, Wilcox ML, et al. A lean pork-containing breakfast reduces hunger and glycemic response compared to a refined carbohydrate-containing breakfast in adults with prediabetes. J Am Coll Nutr. 2018;37(4):293–301.
  • Maki KC, Palacios OM, Lindner E, et al. Replacement of refined starches and added sugars with egg protein and unsaturated fats increases insulin sensitivity and lowers triglycerides in overweight or obese adults with elevated triglycerides. J Nutr. 2017;147(7):1267–1274.
  • Gadgil MD, Appel LJ, Yeung E, et al. The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial. Diabetes Care. 2013;36(5):1132–1137.
  • Hill AM, Harris Jackson KA, Roussell MA, et al. Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial. Am J Clin Nutr. 2015;102(4):757–770.
  • Maki KC, Slavin JL, Rains TM, et al. Limitations of observational evidence: implications for evidence-based dietary recommendations. Adv Nutr. 2014;5(1):7–15.
  • Maki KC, Phillips-Eakley AK, Smith KN. The effects of breakfast consumption and composition on metabolic wellness with a focus on carbohydrate metabolism. Adv Nutr. 2016;7(3):613S–621S.
  • Bi H, Gan Y, Yang C, et al. Breakfast skipping and the risk of type 2 diabetes: a meta-analysis of observational studies. Public Health Nutr. 2015;18(16):3013–3019.
  • Saad A, Dalla Man C, Nandy DK, et al. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012;61(11):2691–2700.
  • Morgan LM, Aspostolakou F, Wright J, et al. Diurnal variations in peripheral insulin resistance and plasma non-esterified fatty acid concentrations: a possible link? Ann Clin Biochem. 1999;36(Pt 4):447–450.
  • Yoshino J, Almeda-Valdes P, Patterson BW, et al. Diurnal variation in insulin sensitivity of glucose metabolism is associated with diurnal variations in whole-body and cellular fatty acid metabolism in metabolically normal women. J Clin Endocrinol Metab. 2014;99(9):E1666–1670.
  • Jakubowicz D, Barnea M, Wainstein J, et al. High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity (Silver Spring). 2013;21(12):2504–2512.
  • Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S76–99.
  • Ardisson Korat AV, Willett WC, Hu FB. Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the nurses’ health study, nurses’ health study 2, and health professionals’ follow-up study. Curr Nutr Rep. 2014;3(4):345–354.
  • Xiao JB, Hogger P. Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem. 2015;22(1):23–38.
  • Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem Toxicol. 2015;83:111–124.
  • Tedong L, Madiraju P, Martineau LC, et al. Hydro-ethanolic extract of cashew tree (Anacardium occidentale) nut and its principal compound, anacardic acid, stimulate glucose uptake in C2C12 muscle cells. Mol Nutr Food Res. 2010;54(12):1753–1762.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.